Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
9%(1 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_4
2
15%
Ph phase_1
1
8%
Ph not_applicable
8
62%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(11)
Other(2)

Detailed Status

Completed11
unknown2

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 42 (16.7%)
N/A8 (66.7%)

Trials by Status

unknown215%
completed1185%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
13